Development and validation of a stability-indicating LC method for determining Palonosetron hydrochloride, its related compounds and degradation products using naphthalethyl stationary phase

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 2, 2011, Pages 429-435

  Vishnu Murthy, M ^a,b   Srinivas, Katkam ^a   Kumar, Ramesh ^a   Mukkanti, K ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Column liquid chromatography; Forced degradation and validation; Naphthalethyl stationary phase; Palonosetron hydrochloride

Indexed keywords

PALONOSETRON;

ARTICLE; DRUG DEGRADATION; DRUG IMPURITY; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; ISOQUINOLINES; MOLECULAR STRUCTURE; NAPHTHALENES; PHOTOLYSIS; QUINUCLIDINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SEROTONIN ANTAGONISTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 79960058410     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.05.037     Document Type: Article

References (21)

1. Drugs acting on 5-hydroxytryptamine receptors. Lancet 1989, 2(September (8665)):717-719.
2. Reynolds R.C. Prokinetic agents: a key in the future of gastroenterology. Gastroenterol. Clin. N.A. 1989, 18:437-457.
3. De Leon A. Palonosetron (Aloxi): a second generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting. Proc. Bayl Univ. Med. Cent. 2006, 19:413-416.
4. Stacher G. Palonosetron (Helsinn). Curr. Opin. Investig. Drugs 2002, 3:1502-1507.
5. Kowalczyk B.A., Dyson N.H. Hydrogenation of a chiral 1H-benz[de]isoquinolin-1-one and an equilibration using palladium catalyst. Org. Process Res. Dev. 1997, 1:117-120.
6. Clark R.D., Miller A.B., Berger J., Repke D.B., Weinhardt K.K., Kowalczyk B.A., Eglen R.M., Bonhaus D.W., Lee C.H. 2-(Quinuclidin-3-yl)pyrido[4 3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists. J. Med. Chem. 1993, 36:2645-2657.
7. Stoltz R., Cyong J.C., Shah A., Parisi S. Pharmacokinetic and safety evaluation of Palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese Healthy subjects. J. Clin. Pharmacol. 2004, 44:520-531.
8. Hunt T.L., Gallegher S.C., Cullen M., Shah A.K. Evaluation of safety and pharmacokinetics of consecutive multiple-day dosing of Palonosetron in healthy subjects. J. Clin. Pharmacol. 2005, 44:589-596.
9. Ding L., Chen Y., Yang L., Wen A. Determination of Palonosetron in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. J. Pharm. Biomed. Anal. 2007, 44:575-580.
10. Zhang W., Feng F. Sensitive and selective LC-MS-MS assay for the quantification of Palonosetron in human plasma and its application to a pharmacokinetic study. Chromatographia 2008, 68:193-199.
11. Tian K., Chen H., Tang J., Chen X., Hu Z. Enantioseparation of PALO by micellar electrokinetic chromatography with sodium cholate as chiral selector. J. Chromatogr. A 2006, 1132:333-336.
12. Radhakrishnanand P., Subba Rao D.V., Hima bindu V. Validated chiral LC method for the enantiomeric separation of PALO. Chromatographia 2008, 69:369-373.
13. Xiao-rong Y.U., Min S.O.N.G., Tai-jun H.A.N.G. Direct enantiomeric separation of PALO by chiral HPLC. Chin. J. New Drugs 2008, 10.
14. Xi S.H.E.N., Hui Z.H.O.U., Wan-qing W.A.N.G., Hua-fang C.A.I. Determination of PALO and its related substances by RP-HPLC 2007, 24:307-308.
15. Xiao-xia S.H.E.N., Xiao-dong L.I.U., Qiang O. RP-ion pair HPLC determination of PALO injection and it's related substances. Chin. J. Pharm. Anal. 2008, 01.
16. http://www.hichrom.co.uk/assets/Products/NacalaiTesque/Cosmosil/COSMOSIL_.piNAP.pdf.
17. Stability testing of new drug substances and products Q1A (R2), step 4 Version. International Conference on Harmonization 2003.
18. Validation of analytical procedures: text and methodology Q2 (R1), step 4 Version. International Conference on Harmonization 2005.
19. Jeannie H., Maier N.M., Wolfgang L Investigations on the chromatographic behavior of hybrid reversed-phase materials containing electron donor-acceptor systems. II. Contribution of π-π aromatic interactions. J. Chromatogr. A 2004, 1045:43-58.
20. p. 12. http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_Scientific_Discussion/human/000563/WC500024256.pdf.
21. p. 15. http://www.info.pmda.go.jp/shinyaku/P201000003/400107000_22200AMX00247_F100_1.pdf.